AbsoluteDx™
Cardiovascular Disease Risk Stratification
Key Facts
About Allelica
Allelica is a US-based diagnostics company founded in 2015, focused on translating polygenic risk scores (PRS) into clinical practice. The company offers a dual business model: a direct-to-physician diagnostic service with tests like AbsoluteDx™ and Breast Risk Reveal™, and a bioinformatics software platform (Allelica Precision Server) for laboratories. Its core value proposition is providing validated, multi-ancestry PRS that integrate with existing clinical risk models to identify patients with elevated genetic risk missed by traditional tools like LDL-C or family history. Allelica is positioning itself at the forefront of the precision prevention movement, with its technology cited in emerging clinical guidelines.
View full company profile